Xinlan Lu

1.0k total citations
40 papers, 790 citations indexed

About

Xinlan Lu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinlan Lu has authored 40 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinlan Lu's work include MicroRNA in disease regulation (9 papers), Gastric Cancer Management and Outcomes (9 papers) and Circular RNAs in diseases (8 papers). Xinlan Lu is often cited by papers focused on MicroRNA in disease regulation (9 papers), Gastric Cancer Management and Outcomes (9 papers) and Circular RNAs in diseases (8 papers). Xinlan Lu collaborates with scholars based in China, Australia and Japan. Xinlan Lu's co-authors include Mudan Ren, Shuixiang He, Yarui Li, Yan Zhao, Guifang Lu, Guifang Lu, Dan Guo, Dan Zhang, Xin Wang and Shuixiang He and has published in prestigious journals such as PLoS ONE, Cancer Research and Langmuir.

In The Last Decade

Xinlan Lu

38 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinlan Lu China 17 487 368 141 117 88 40 790
Weilong Chang China 17 340 0.7× 170 0.5× 134 1.0× 121 1.0× 227 2.6× 32 668
Xiefu Zhang China 21 661 1.4× 501 1.4× 84 0.6× 105 0.9× 161 1.8× 42 971
Xianghong Yang China 16 353 0.7× 153 0.4× 117 0.8× 102 0.9× 290 3.3× 35 719
Baixia Yang China 13 269 0.6× 196 0.5× 71 0.5× 81 0.7× 117 1.3× 22 502
Kezhen Lv China 13 396 0.8× 285 0.8× 56 0.4× 76 0.6× 169 1.9× 15 654
Jieting Tang China 14 556 1.1× 405 1.1× 85 0.6× 70 0.6× 175 2.0× 31 966
Qiujun Guo China 14 270 0.6× 140 0.4× 183 1.3× 248 2.1× 235 2.7× 27 761
C-W Wu Taiwan 10 283 0.6× 159 0.4× 102 0.7× 86 0.7× 168 1.9× 10 595
Jichao Wei China 12 300 0.6× 179 0.5× 75 0.5× 65 0.6× 121 1.4× 22 557

Countries citing papers authored by Xinlan Lu

Since Specialization
Citations

This map shows the geographic impact of Xinlan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlan Lu more than expected).

Fields of papers citing papers by Xinlan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinlan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlan Lu. The network helps show where Xinlan Lu may publish in the future.

Co-authorship network of co-authors of Xinlan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinlan Lu. A scholar is included among the top collaborators of Xinlan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinlan Lu. Xinlan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Xinlan, Min Qiang, Rufeng Li, et al.. (2025). Multi-omics profiling reveals downregulated tumor lysine metabolism reshaping the immune microenvironment and therapeutic responses in hepatocellular carcinoma. Journal of Translational Medicine. 23(1). 1117–1117.
2.
Li, Shaochen, Xinlan Lu, Shan Xu, et al.. (2024). SCAG: A Stratified, Clustered, and Growing-Based Algorithm for Soybean Branch Angle Extraction and Ideal Plant Architecture Evaluation. Plant Phenomics. 6. 190–190. 3 indexed citations
3.
Tu, Rongfu, Junpeng Ma, Yule Chen, et al.. (2024). USP7 depletion potentiates HIF2α degradation and inhibits clear cell renal cell carcinoma progression. Cell Death and Disease. 15(10). 749–749. 2 indexed citations
4.
Zhao, Xiong, Li Ma, Junsheng Hou, et al.. (2024). Acoustofluidic one-step production of plasmonic Ag nanoparticles for portable paper-based ultrasensitive SERS detection of bactericides. Journal of Colloid and Interface Science. 673. 426–433. 12 indexed citations
6.
Wang, Ruhua, Yunong Fu, Menglin Yao, et al.. (2022). The HN1 / HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin. FEBS Journal. 289(20). 6400–6419. 17 indexed citations
8.
Zhang, Xu, Wenwen Chen, Dan Guo, et al.. (2022). Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p/STARD13 regulatory axis. Biological Procedures Online. 24(1). 14–14. 6 indexed citations
9.
Feng, Lin, Mudan Ren, Yan Zhao, et al.. (2021). Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis. Digestive Diseases and Sciences. 67(8). 3763–3772. 14 indexed citations
10.
Zhao, Yan, Mudan Ren, Guifang Lu, et al.. (2020). The Prognosis Analysis of Liver Cirrhosis with Acute Variceal Bleeding and Validation of Current Prognostic Models: A Large Scale Retrospective Cohort Study. BioMed Research International. 2020(1). 7372868–7372868. 15 indexed citations
11.
Zhao, Yan, Mudan Ren, Xin Wang, et al.. (2020). Telephone-Based Reeducation of Drug Administration for Helicobacterpylori Eradication: A Multicenter Randomized Controlled Study. Gastroenterology Research and Practice. 2020. 1–6. 9 indexed citations
12.
Zhao, Yan, Yarui Li, Xin Wang, et al.. (2020). The Effect of <b><i>Helicobacter pylori</i></b> Eradication in Patients with Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Studies. Digestive Diseases. 38(4). 261–268. 28 indexed citations
13.
Zhang, Zhiyong, Li Ren, Qian Zhao, et al.. (2020). TRPC1 exacerbate metastasis in gastric cancer via ciRS-7/miR-135a-5p/TRPC1 axis. Biochemical and Biophysical Research Communications. 529(1). 85–90. 26 indexed citations
15.
Zhang, Ning, et al.. (2018). Negative Regulation of Kruppel-Like Factor 4 on microRNA-106a at Upstream Transcriptional Level and the Role in Gastric Cancer Metastasis. Digestive Diseases and Sciences. 63(10). 2604–2616. 5 indexed citations
16.
Li, Yarui, Dan Guo, Yan Zhao, et al.. (2018). Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3β signal pathway. Cell Death and Disease. 9(9). 888–888. 109 indexed citations
17.
Li, Yarui, Mudan Ren, Yan Zhao, et al.. (2017). MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis. Oncology Reports. 37(6). 3527–3535. 41 indexed citations
18.
Zhao, Yan, Guifang Lu, Xiquan Ke, et al.. (2016). miR-488 acts as a tumor suppressor gene in gastric cancer. Tumor Biology. 37(7). 8691–8698. 42 indexed citations
19.
Lu, Xinlan, et al.. (2015). Caspase-mediated iASPP cleavage inhibits NF-kB. Cancer Research. 75. 1 indexed citations
20.
Lu, Guifang, Tao Shan, Shuixiang He, et al.. (2013). Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival. Oncology Reports. 30(5). 2238–2244. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026